Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,652,918 papers from all fields of science
Search
Sign In
Create Free Account
Kidneys, Artificial
Known as:
Artificial Kidney
, Blood Dialyzer
, Dialyzer, Blood
Expand
Devices which can substitute for normally functioning KIDNEYS in removing components from the blood by DIALYSIS that are normally eliminated in the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Broader (1)
DIALYZER
Narrower (4)
DIALYZER, DISPOSABLE
HEMODIALYZER, RE-USE, HIGH FLUX
Hemodialysis machine
Renal Dialysis Machine
Dialysis procedure
Hemodialysis
Hemodialyzates
Microbiological
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1999
Highly Cited
1999
Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project.
D. Frankenfield
,
M. Rocco
,
P. Frederick
,
Jacqueline A. Pugh
,
W. McClellan
,
W. Owen
American Journal of Kidney Diseases
1999
Corpus ID: 23521224
Highly Cited
1998
Highly Cited
1998
Soluble P-Selectin Is Released from Activated Platelets in vivo during Hemodialysis
K. Kawabata
,
Y. Nagake
,
+5 authors
H. Makino
Nephron
1998
Corpus ID: 21083315
During hemodialysis, platelets are activated across a dialyzer. Soluble P-selectin (sP-selectin) is a form of P-selectin which is…
Expand
Highly Cited
1997
Highly Cited
1997
Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
G. Nowak
,
E. Bucha
,
I. Brauns
,
R. Czerwinski
Wiener Klinische Wochenschrift
1997
Corpus ID: 19682519
A 69-year-old female patient with renal failure developed heparin-induced thrombocytopenia type II (HIT II) two months after…
Expand
Highly Cited
1989
Highly Cited
1989
Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers.
D. Lanese
,
Patricia S. Alfrey
,
B. Molitoris
Kidney International
1989
Corpus ID: 20990526
Clearance of a drug during hemodialysis is affected by drug specific, membrane specific and dialysis specific factors [1, 2…
Expand
Highly Cited
1989
Highly Cited
1989
Identification of plasma proteins adsorbed to hemodialyzers during clinical use.
S. Mulzer
,
J. Brash
Journal of Biomedical Materials Research
1989
Corpus ID: 26101306
An investigation has been made of the protein layers formed on hemodialysis membranes during clinical use. Dialyzers having…
Expand
Highly Cited
1987
Highly Cited
1987
Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure.
H. Saxenhofer
,
M. Gnädinger
,
+5 authors
H. Jahn
Kidney International
1987
Corpus ID: 3187886
Plasma immunoreactive atrial natriuretic peptide (irANP) levels, their chromatographic profile, relationship with hemodynamic…
Expand
Review
1983
Review
1983
Choosing a membrane.
Lee W. Henderson
,
Alfred K. Cheung
,
Dennis E. Chenoweth
American Journal of Kidney Diseases
1983
Corpus ID: 26965539
Highly Cited
1977
Highly Cited
1977
Drug Kinetics and Artificial Kidneys
T. Gibson
,
H. Nelson
Clinical Pharmacokinetics
1977
Corpus ID: 37536874
The factors affecting solute movement across the membrane during haemodialysis are well understood. Likewise the mathematics of…
Expand
Highly Cited
1976
Highly Cited
1976
Artificial kidneys and clearance calculations
T. Gibson
,
E. Matusik
,
L. Nelson
,
W. Briggs
Clinical pharmacology and therapy
1976
Corpus ID: 37942708
Clearance of solutes by artificial kidneys can be calculated using plasma flow and solute concentration, whole blood flow and…
Expand
Highly Cited
1966
Highly Cited
1966
Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices.
M. As
1966
Corpus ID: 68334406
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE